We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+3.42%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.74B
AUM Growth
+$3.96M
Cap. Flow
-$26.1M
Cap. Flow %
-1.51%
Top 10 Hldgs %
15.35%
Holding
320
New
26
Increased
74
Reduced
161
Closed
25

Top Sells

Rank Stock Value
1
NICE icon
Nice
NICE
+$21.2M
2
KFY icon
Korn Ferry
KFY
+$20.9M
3
CRAY
Cray, Inc.
CRAY
+$18M
4
ACH
Accendra Health
ACH
+$17.9M
5
RRGB icon
Red Robin
RRGB
+$15.8M

Sector Composition

Rank Sector Weight
1 Industrials 22.31%
2 Healthcare 18.93%
3 Technology 18.27%
4 Consumer Discretionary 12.44%
5 Financials 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTC icon
26
PTC
PTC
$15.8B
$17.7M 1.02%
471,908
-4,977
-1% -$178K
SLAB icon
27
Silicon Laboratories
SLAB
$7.17B
$17.5M 1.01%
359,287
-5,220
-1% -$246K
AMRI
28
DELISTED
Albany Molecular Research Inc
AMRI
$17.4M 1%
1,297,212
-21,019
-2% -$307K
AIN icon
29
Albany International
AIN
$2.11B
$17.4M 1%
436,152
-5,364
-1% -$212K
FIVE icon
30
Five Below
FIVE
$12B
$17M 0.98%
365,715
-15,248
-4% -$637K
EHC icon
31
Encompass Health
EHC
$11B
$16.9M 0.97%
545,938
-5,986
-1% -$187K
RAMP icon
32
LiveRamp
RAMP
$2.3B
$16.8M 0.97%
765,176
-281,949
-27% -$6.12M
PEGA icon
33
Pegasystems
PEGA
$5.02B
$16.6M 0.95%
1,228,258
-614,500
-33% -$8.1M
GMED icon
34
Globus Medical
GMED
$10.7B
$16.5M 0.95%
+693,056
New +$16.6M
CATY icon
35
Cathay General Bancorp
CATY
$4.22B
$16.5M 0.95%
584,875
-7,385
-1% -$219K
LCII icon
36
LCI Industries
LCII
$2.49B
$16.4M 0.95%
193,644
+2,730
+1% +$197K
DORM icon
37
Dorman Products
DORM
$3.98B
$16.4M 0.94%
286,384
+71,345
+33% +$3.83M
CMPR icon
38
Cimpress
CMPR
$2.39B
$16.4M 0.94%
176,867
-10,163
-5% -$953K
HAWK
39
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$16.3M 0.94%
485,220
-139,474
-22% -$4.66M
SFLY
40
DELISTED
Shutterfly, Inc.
SFLY
$16.2M 0.93%
347,523
+2,637
+0.8% +$124K
MYGN icon
41
Myriad Genetics
MYGN
$270M
$16.1M 0.93%
+526,184
New +$18.3M
CEB
42
DELISTED
CEB Inc.
CEB
$16M 0.92%
259,186
+3,598
+1% +$225K
XXIA
43
DELISTED
Ixia
XXIA
$15.9M 0.92%
1,620,311
-18,260
-1% -$188K
TMH
44
DELISTED
Team Health Holdings Inc
TMH
$15.8M 0.91%
389,733
-4,137
-1% -$180K
AMBA icon
45
Ambarella
AMBA
$3.77B
$15.8M 0.91%
310,746
+99,502
+47% +$4.4M
BSFT
46
DELISTED
BroadSoft, Inc.
BSFT
$15.7M 0.9%
+382,712
New +$15.8M
PRLB icon
47
Protolabs
PRLB
$1.79B
$15.6M 0.9%
271,806
+118,787
+78% +$7.93M
AMN icon
48
AMN Healthcare
AMN
$1.3B
$15.6M 0.9%
389,496
-191,617
-33% -$7.09M
GBCI icon
49
Glacier Bancorp
GBCI
$6.42B
$15.5M 0.89%
581,787
-6,516
-1% -$169K
COHR
50
DELISTED
Coherent Inc
COHR
$15.1M 0.87%
164,136
-2,334
-1% -$215K

Similar funds

Rice Hall James & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Rice Hall James & Associates held 320 positions worth $1.74B, up 0.23% from $1.73B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q2 2016 filing shows 26 new, 74 increased, 161 reduced and 25 closed positions. Its largest new stake was Fleetmatics Group PLC: 700,254 shares worth $30.3M. The largest sale was Nice, an estimated $21.2M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

  • Rice Hall James & Associates's largest Q2 2016 buy was Fleetmatics Group PLC: 700,254 shares worth $30.3M.
  • Rice Hall James & Associates added most to Deckers Outdoor in Q2 2016, an estimated $8.2M increase.
  • Rice Hall James & Associates's biggest Q2 2016 reduction was Pegasystems, cutting an estimated $8.1M.
  • Rice Hall James & Associates fully exited Nice in Q2 2016, selling an estimated $21.2M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.74B portfolio in Q2 2016.
  • Rice Hall James & Associates opened 26 new positions and closed 25 in Q2 2016.
  • Rice Hall James & Associates's portfolio value rose 0.23% quarter-over-quarter to $1.74B.

Based on Rice Hall James & Associates's 13F filing for Q2 2016, filed 27 Jul 2016.